MBD6 and leukemia: Overall, this experimental study demonstrated for the first time that the NSUN2-TET2-MBD6-BAP1/PR-DUB axis in human leukaemias (and most likely in other malignancies as well) is the key underlying mechanism for leukaemogenesis and carcinogenesis in TET2-depleted cells.